Endoscopic ultrasound guided transgastric stenting for the treatment of traumatic pancreatic pseudocyst.
Endoscopic treatment for pancreatic pseudocysts (PPs) is a relatively new alternative to surgery. This study is to prospectively assess the value of endoscopic ultrasound (EUS) guided transgastric stenting in treatment of traumatic PPs. Between January 2005 and January 2010, 14 patients admitted to our centre for traumatic PPs underwent EUS guided transgastric stenting. The clinical data about the therapies and recovery of the patients was recorded and analyzed. All patients underwent EUS and a total of 21 EUS guided transgastric stentings were performed with a success rate of 90.5% (19/21); 2 patients required surgery because therapeutic endoscopy was unsuccessful or impossible. The mean operative time was 46min and mean postoperative hospital duration was 3.8 days. There was no procedure-related mortality. The complication rate was 19.0%with 2 infections of PPs and 2 stent obstructions. The median follow-up period was 29 months (range, 10-58 months). No recurrence or other complications were found. Endoscopic ultrasound guided transgastric stenting can be selected as a safe, effective and minimally invasive therapeutic method for traumatic PPs. More than 6 months of stent retention for traumatic PP may be reasonable, but larger comparative studies are still needed.